These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

199 related items for PubMed ID: 3861611

  • 21. HLA class II DNA genotypes in Graves' disease: clues to inheritance of the HLA-linked component of susceptibility.
    Fletcher J, Franklyn JA, McLachlan SM, Young E, Sheppard MC.
    Clin Endocrinol (Oxf); 1988 Nov; 29(5):539-47. PubMed ID: 2908104
    [Abstract] [Full Text] [Related]

  • 22. HLA and rheumatoid arthritis: an analysis of multicase families.
    Ollier W, Silman A, Gosnell N, Currey H, Awad J, Doyle P, McCloskey D, Alonso A, Hossain MA, Festenstein H.
    Dis Markers; 1986 Jun; 4(1-2):85-98. PubMed ID: 3330700
    [Abstract] [Full Text] [Related]

  • 23. Immunogenetics of Hashimoto's and Graves' diseases.
    Tamai H, Uno H, Hirota Y, Matsubayashi S, Kuma K, Matsumoto H, Kumagai LF, Sasazuki T, Nagataki S.
    J Clin Endocrinol Metab; 1985 Jan; 60(1):62-6. PubMed ID: 3838076
    [Abstract] [Full Text] [Related]

  • 24. HLA haplotypes and susceptibility to Graves' disease.
    De Rosa G, Testa A, Mariani M, Purpura M, Giacomini D.
    Horm Res; 1992 Jan; 37(4-5):176-9. PubMed ID: 1490660
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Correlation of HLA types and clinical findings in Japanese patients with hyperthyroid Graves' disease: evidence indicating the existence of four subpopulations.
    Inoue D, Sato K, Enomoto T, Sugawa H, Maeda M, Inoko H, Tsuji K, Mori T, Imura H.
    Clin Endocrinol (Oxf); 1992 Jan; 36(1):75-82. PubMed ID: 1559302
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Association of HLA-DR tissue types with Graves' disease in Taiwan.
    Tsai KS, Hsieh RP, Chang CC, Chen FW, Lee SC.
    Taiwan Yi Xue Hui Za Zhi; 1989 Apr; 88(4):336-41. PubMed ID: 2794934
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. HLA antigens and susceptibility to myasthenia gravis.
    Matej H, Nowakowska B, Kałamarz M, Paradowski B, Podemski R, Brzecki A.
    Arch Immunol Ther Exp (Warsz); 1987 Apr; 35(6):795-801. PubMed ID: 3508039
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. MHC related genetic susceptibility to Hodgkin's disease.
    Kalidi I, Masset M, Gony J, Marcelli A, Jeannet M, Irlé C, Bauters F, Tchernia G, Turpin F, Gisselbrecht C.
    Nouv Rev Fr Hematol (1978); 1989 Apr; 31(2):149-52. PubMed ID: 2771630
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Human leukocyte antigen (HLA)-linked control of susceptibility to pulmonary tuberculosis and association with HLA-DR types.
    Singh SP, Mehra NK, Dingley HB, Pande JN, Vaidya MC.
    J Infect Dis; 1983 Oct; 148(4):676-81. PubMed ID: 6415179
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.